| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5528163 | Lung Cancer | 2017 | 8 Pages |
Abstract
The development of new immune treatment in oncology and particularly for lung cancer may induce new complications, particularly activation or reactivation of auto-immune diseases. In this context, a systematic review on the auto-immune paraneoplastic syndromes associated with lung cancer appears useful. This article is the first of a series of five and deals with the methodology applied for the review and with renal and rheumatic syndromes.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Valérie Durieux, Michelle Coureau, Anne-Pascale Meert, Thierry Berghmans, Jean-Paul Sculier,